featured
Eribulin Mesilate in Combination With Capecitabine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine
Br. J. Cancer 2019 Feb 20;[EPub Ahead of Print], C Twelves, A Anthoney, CI Savulsky, M Guo, L Reyderman, N Cresti, V Semiglazov, C Timcheva, I Zubairi, R Morrison, R Plummer, TRJ EvansFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.